Floatz logo

Recombinant Human Granulocyte Colony-Stimulating Factor

Myeloid Neoplasm

University of WashingtonUNKNOWNPhase 2Active
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
89/ 100

Competitive context

27 Active assets in the Myeloid Neoplasm cohort.

Asset / SponsorPhaseRating
Mitoxantrone
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cytarabine
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cladribine
University of Washington
Phase 2BBB
Cyclophosphamide
Prelude Therapeutics
Phase 3BB
METHOTREXATE
St. Jude Children's Research Hospital
Phase 3BB

View all 46 →

Same molecule, other indications

Recombinant Human Granulocyte Colony-Stimulating Factor is also rated in:

acute myeloid leukemiaActive
B
Indicative · Phase 2
60 / 100
View asset →
chronic myelomonocytic leukemiaActive
CCC
Indicative · Phase 2
55 / 100
View asset →
plasma cell myelomaActive
CCC
Indicative · Phase 4
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →